|
|
|
|
| LEADER |
02484nmm a2200301 u 4500 |
| 001 |
EB000674208 |
| 003 |
EBX01000000000000000527290 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642781544
|
| 100 |
1 |
|
|a Gad, Adel
|e [editor]
|
| 245 |
0 |
0 |
|a Breast Cancer Screening in Europe
|h Elektronische Ressource
|c edited by Adel Gad, Marco Rosselli Del Turco
|
| 250 |
|
|
|a 1st ed. 1993
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1993, 1993
|
| 300 |
|
|
|a VIII, 148 p
|b online resource
|
| 505 |
0 |
|
|a Breast Cancer: The Scene in Europe -- Overview of European Screening Programmes -- Evidence of the Effectiveness of Breast Cancer Screening -- Cost-Effectiveness Analysis of Breast Cancer Screening -- Programme Organisation in Breast Cancer Screening -- Compliance in Breast Cancer Screening: the Spanish Experience -- Breast Cancer Screening in Montpellier -- The Bas-Rhin Model: A Non-Centralised Screening Programme -- Non-Invasive Breast Cancer: An Important Screening Problem -- Criteria for Recall and Diagnostic Assessment -- Pathology in Breast Cancer Screening: A 15-Year Experience from a Swedish Programme -- Therapeutic Aspects of Screen-Detected Lesions: The Role of the Surgeon -- Monitoring the Impact of a Breast Cancer Screening Programme -- Training in Mammographic Screening -- Quality Control in Mammography -- Quality of Life and Breast Cancer Screening
|
| 653 |
|
|
|a Gynecology
|
| 653 |
|
|
|a Gynecology
|
| 653 |
|
|
|a Oncology
|
| 700 |
1 |
|
|a Rosselli Del Turco, Marco
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a ESO Monographs, European School of Oncology
|
| 028 |
5 |
0 |
|a 10.1007/978-3-642-78154-4
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-78154-4?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.994
|
| 520 |
|
|
|a As controlled trials have demonstrated that in many European countries breast cancer mortality may be reduced by population-based mammographic screening of women over the age of 50, there is mounting pressure to introduce new service screening programmes. How should these programmes be planned and monitored ? Is it cost-effective ? We invited experts whowork with the principal screening programmes in Europe to answer these questions and to describe their experiences. Particualr attention has been given to planning, organisation and monitoring new screening programmes in order to achieve optimal results
|